NTT/SAP
15.9.2016 11:13:23 CEST | Business Wire | Press release
SAP SE (NYSE:SAP) and Nippon Telegraph and Telephone Corporation (NTT) (NYSE:NTT) announced today its partnership enhancement in ‘Co-Innovation’, ‘Cross-Selling of Solutions’ and ‘Global Reference’.
SAP and NTT are collaborating by integrating cutting-edge technologies. As the first project of this initiative, to support safety operation of the transportation industry, the two companies have developed a solution combining SAP’s Connected Transportation Safety (CTS) solutions, which collects and analyzes vehicle related data, with NTT’s hitoe®, sensing fabric jointly developed with Toray Industries, and NTT IoT analytics platform, which provides driver’s biological data including heart rate and mental fatigue estimate, the project aims to provide more accurate and real-time information about vehicle and driver’s condition.
In cooperation with Keifuku Bus Co., Ltd (Fukui, Japan), SAP and NTT Group will conduct a field trial from October 2016, targeting to provide service from January 2017. The companies are planning to rollout this solution in the United States and Europe as well.
“We are honored to partner with NTT group who runs the world’s biggest data centers,” said Rob Enslin, member of the Executive Board of SAP SE and president of Global Customer Operations, SAP. “This partnership brings significant impact on SAP to broaden customers’ choice upon facilitating digital transformation. The integration of NTT’s cutting-edge technologies and SAP’s revolutionary solutions will generate momentum to elevate the overall market to the next level. By closely collaborating on a global scale, NTT and SAP will continuously strengthen ties to drive the three key initiatives including Co-innovation, Global Partnership, and SAP Solution Reference Customer in a long term perspective.”
“NTT aims to contribute to business transformation of its enterprise clients by providing high value-added services with partners.” said Jun Sawada, Senior Executive Vice President of NTT, “Global partnership with SAP is a significant step for strengthening our competitiveness in the rapidly changing ICT market. Through this partnership, along with SAP’s expertise and experiences, NTT can enhance its capabilities to support our global clients, and can accelerate digital transformation of industries.”
This co-innovation effort started in Palo Alto, California and has been led by NTT Labs and SAP Labs China. SAP and NTT Group intend to continue co-innovations in various areas with new technologies and expand its partnership through marketing promotion globally.
SAP and NTT Group have agreed to advance their digital practice collaboration and have formatted a new partner for Industrial Revolution. Primary target for 2016 is to move customers to the cloud for IoT and Industry 4.0.
While the partnership is not limited to Industrial Revolution, both companies are also accelerating their collaboration around private managed cloud solutions such as SAP HANA Enterprise Cloud leveraging NTT’s world class data center network around the globe. NTT is also a S/4 HANA Adoption Pinnacle Award Winner 2016.
In addition, NTT and SAP will create a global reference which could become a universal model. NTT has been working on establishing business platform as well as IT infrastructure to create synergy within the group. To accelerate the process, NTT is going to utilize the latest SAP solutions.
About SAP
As market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device – SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 320,000 customers to operate profitably, adapt continuously, and grow sustainably. The company is traded under the ‘SAP’ brand on the Frankfurt Stock Exchange, the New York Stock Exchange and other major global bourses. For more information, visit www.sap.com .
Copyright© 2016 SAP SE or an SAP affiliate company. All rights reserved.
SAP,
the SAP logo and other SAP products and services mentioned herein as
well as their respective logos are trademarks or registered trademarks
of SAP SE (or an SAP affiliate company) in Germany and other countries.
Other company names, logos, product names, etc. mentioned herein are the
registered trademarks or trademarks of the companies in question.
About Nippon Telegraph and Telephone Corporation (NTT)
NTT Group delivers advanced technology and innovative solutions in
networking, software communications, and cloud computing that help
transform businesses, governments and societies around the world.
NTT
Group will deliver convenient, enriched and reliable services to support
customers as a ‘Value Partner’ that its customers will continue to
select. Today, 85% of Fortune Global 100 companies rely on NTT Group as
their business partner. NTT Group generates over $95 billion in annual
revenues, has over 240 data centers and employs more than 241,000
professionals working in 87 countries. For more information, visit www.ntt-global.com
.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160915005612/en/
Contact:
Media Contacts
SAP Global PR
contact
Jason Loesche
j.loesche@sap.com
or
SAP
Japan Co., Ltd.
Kaori Suzuki, +81-(3) 6737-3880 (division
switchboard); +81-80-1007-5933 (direct line)
Public Relations
kaori.suzuki@sap.com
or
Nippon
Telegraph and Telephone Corporation
Public Relations Office
ntt-cnr-ml@hco.ntt.co.jp
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
